Roberto Furlan
Neuroimmunology Unit-DIBIT
Department of Neurology
San Raffaele Scientific Institute
Via Olgettina 58
Italy
Name/email consistency: high
- Definition of non-responders: biological markers. Furlan, R. Neurol. Sci. (2008)
- HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice. Furlan, R., Bergami, A., Brambilla, E., Butti, E., De Simoni, M.G., Campagnoli, M., Marconi, P., Comi, G., Martino, G. Gene Ther. (2007)
- Immunological patterns identifying disease course and evolution in multiple sclerosis patients. Furlan, R., Rovaris, M., Martinelli Boneschi, F., Khademi, M., Bergami, A., Gironi, M., Deleidi, M., Agosta, F., Franciotta, D., Scarpini, E., Uccelli, A., Zaffaroni, M., Kurne, A., Comi, G., Olsson, T., Filippi, M., Martino, G. J. Neuroimmunol. (2005)
- A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis. Furlan, R., Kurne, A., Bergami, A., Brambilla, E., Maucci, R., Gasparini, L., Butti, E., Comi, G., Ongini, E., Martino, G. J. Neuroimmunol. (2004)
- Gene therapy for autoimmune diseases. Furlan, R., Butti, E., Pluchino, S., Martino, G. Curr. Opin. Mol. Ther. (2004)
- Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma. Furlan, R., Bergami, A., Cantarella, D., Brambilla, E., Taniguchi, M., Dellabona, P., Casorati, G., Martino, G. Eur. J. Immunol. (2003)
- Gene therapy-mediated modulation of immune processes in the central nervous system. Furlan, R., Pluchino, S., Martino, G. Curr. Pharm. Des. (2003)









